UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q/A

  

(Amendment No. 1)

 

(Mark One)

 

x      QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934 

 

For the quarterly period ended September 30, 2015

 

¨      TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934

  

Commission File No.

000-25809

 

Apollo Medical Holdings, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware 46-3837784
State of Incorporation IRS Employer Identification No.

 

700 North Brand Blvd., Suite 1400

Glendale, California 91203

(Address of principal executive offices)

 

(818) 396-8050

(Issuer’s telephone number) 

 

(Former name, former address and former fiscal year, if changed since last report)

 

Securities Registered Pursuant to Section 12(b) of the Act:

 

Title of each Class   Name of each Exchange on which Registered
    None

 

Securities Registered Pursuant to Section 12(g) of the Act:

Common Stock, $.001 Par Value

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days:   x  Yes     ¨   No.

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).     x  Yes     ¨   No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.

 

Large accelerated filer       ¨ Accelerated filer       ¨
   
Non-accelerated filer         ¨ Smaller reporting company      x

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act):    ¨  Yes      x   No

 

As of November 10, 2015, there were 4,863,389 shares of common stock, $.001 par value per share, issued and outstanding.

 

 

 

 

Explanatory Note

 

Apollo Medical Holdings, Inc. (the “Company”) is filing this Amendment No. 1 to its Quarterly Report on Form 10-Q for the quarter ended September 30, 2015, filed with the Securities and Exchange Commission on November 16, 2015 (“Form 10-Q”), for the sole purpose of submitting Exhibit 101 to the Form 10-Q. Exhibit 101 consists of the Interactive Data Files for the Company’s Form 10-Q for the quarter ended September 30, 2015.

 

No other changes have been made to the Form 10-Q. This Amendment No. 1 speaks only as of the original filing date of the Form 10-Q, does not reflect events that may have occurred subsequent to such original filing date and does not modify or update in any way disclosures made in the Form 10-Q.

  

 

 

 

ITEM 6.  EXHIBITS

 

Exhibit
No.		   Description
     
3.1**   Certificate of Incorporation, as amended on October 16, 2015
     
3.2**   Restated Bylaws, as amended on October 12, 2015
     

 

 

 

 

Exhibit
No.		   Description
     
31.1*   Certification by Chief Executive Officer
     
31.2*   Certification by Chief Financial Officer
     
32.1*   Certification by Chief Executive Officer pursuant to 18 U.S.C. section 1350.
     
32.2*   Certification by Chief Financial Officer pursuant to 18 U.S.C. section 1350
     
101.INS*   XBRL Instance Document.
     
101.SCH*   XBRL Taxonomy Extension Schema Document.
     
101.CAL*   XBRL Taxonomy Extension Calculation Linkbase Document.
     
101.DEF*   XBRL Taxonomy Extension Definition Linkbase
     
101.LAB*   XBRL Taxonomy Extension Label Linkbase Document.
     
101.PRE*   XBRL Taxonomy Extension Presentation Linkbase Document.

 

  *   Filed herewith.
    ** Previously Filed

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  APOLLO MEDICAL HOLDINGS, INC.
     
     
Dated:  November 16, 2015 By: /s/ William R. Abbott
    William R. Abbott
    Chief Financial Officer
    (Principal Financial and Accounting Officer)